Trademark applications and grants for Scpharmaceuticals, Inc.. Scpharmaceuticals, Inc. has 7 trademark applications. The latest application filed is for "FUROSCIX DIRECT"
State Incorporated | MASSACHUSETTS |
Entity Type | CORPORATION |
Address | 2400 District Avenue, Suite 310 Burlington, MASSACHUSETTS UNITED STATES 01803 |
Patent Application | Date |
---|---|
CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE 20220168323 - 17/675043 Grossi; Alfredo ;   et al. | 2022-06-02 |
CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE AND METHODS OF ADMINISTERING THE SAME 20220096500 - 17/426765 Grossi; Alfredo ;   et al. | 2022-03-31 |
PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE 20200038364 - 16/295085 Michaels; Scott A. ;   et al. | 2020-02-06 |
PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE 20180303790 - 15/877865 Michaels; Scott A. ;   et al. | 2018-10-25 |
Combination Therapy for Subcutaneous Administration of Glycopeptide Antibiotics 20160082075 - 14/779693 Muntendam; Pieter | 2016-03-24 |
NCAGE Code | 73Y45 | SCPHARMACEUTICALS INC. |
CAGE Code | 73Y45 | SCPHARMACEUTICALS INC. |
SEC | 0001604950 | scPharmaceuticals Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.